Blog

Stephen D. Nimer’s recent study could lead to a new combination therapy for leukemia

Photo taken from Sylvester Comprehensive Cancer Center/X

May 23, 2024, 09:19

Stephen D. Nimer’s recent study could lead to a new combination therapy for leukemia

Sylvester Comprehensive Cancer Center shared a post on X:

“Stephen D. Nimer’s recent study could lead to a new combination therapy for leukemia. Featuring Sylvester’s collaboration with first author Hidehiro Itonaga, Ph.D., and other researchers, learn how the study could inform FDA development of new treatments.”

Read further.
Source: Sylvester Comprehensive Cancer Center/X
.

cancer cancer collaboration Cancer research Cancer Therapy Advancements combination therapy FDA development Hematology Hidehiro Itonaga Leukemia leukemia treatment Medical Research new treatments OncoDaily Oncology Stephen D. Nimer Sylvester collaboration Sylvester Comprehensive Cancer Center

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage